Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T L Holyoake

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Leukemia|January 31, 2012
Gfi-1 inhibits proliferation and colony formation of p210BCR/ABL-expressing cells via transcriptional repression of STAT 5 and Mcl-1A R Soliera, S A Mariani, A Audia, et al.
Leukemia|January 28, 2005
Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human diseaseW Eisterer, X Jiang, O Christ, et al.
Clinical and Experimental Immunology|November 18, 2003
No strong relationship between mannan binding lectin or plasma ficolins and chemotherapy-related infectionsD C Kilpatrick, L A McLintock, E K Allan, et al.
Leukemia|December 2, 2015
Mtss1 is a critical epigenetically regulated tumor suppressor in CMLM Schemionek, O Herrmann, M M Reher, et al.
Leukemia|January 12, 2020
A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual diseaseG A Horne, J Stobo, C Kelly, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Leukemia|January 31, 2012
Gfi-1 inhibits proliferation and colony formation of p210BCR/ABL-expressing cells via transcriptional repression of STAT 5 and Mcl-1A R Soliera, S A Mariani, A Audia, et al.
Leukemia|January 28, 2005
Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human diseaseW Eisterer, X Jiang, O Christ, et al.
Clinical and Experimental Immunology|November 18, 2003
No strong relationship between mannan binding lectin or plasma ficolins and chemotherapy-related infectionsD C Kilpatrick, L A McLintock, E K Allan, et al.
Leukemia|December 2, 2015
Mtss1 is a critical epigenetically regulated tumor suppressor in CMLM Schemionek, O Herrmann, M M Reher, et al.
Leukemia|January 12, 2020
A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual diseaseG A Horne, J Stobo, C Kelly, et al.
Pageof 7